ABBOTINDIA

Abbott India Financial Results

₹26,075.00-0.15%
Market cap
₹55,408 crore
P/E
34.3
P/B
11.61
ROE
34.5%
Dividend yield
2.52%

For the year ended Mar 2023, Abbott India reported revenue of ₹5,347 crore and net profit of ₹949 crore, against ₹5,847 crore and ₹1,201 crore a year earlier.

Abbott India annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Abbott India annual profit and loss (₹ crore)
ItemMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue5,3475,8476,4076,9277,004
Expenses4,1294,3704,6915,0265,035
Operating profit1,2171,4771,7161,9011,969
Operating margin %23%25%27%27%28%
Other income143225254279291
Interest1612112525
Depreciation7071727676
Profit before tax1,2741,6181,8872,0792,158
Tax %25%26%25%25%25%
Net profit9491,2011,4141,5521,615
EPS (₹)446.80565.30665.64730.39759.87
Dividend payout %—————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Abbott India financial results — frequently asked questions

What is Abbott India's annual revenue and net profit?

For the financial year ended Mar 2023, Abbott India's revenue was ₹5,347 crore and net profit ₹949 crore; net profit fell 20.98% from ₹1,201 crore in Mar 2024.

How fast has Abbott India grown over three years?

From Mar 2026 to Mar 2023, Abbott India's revenue grew at a compound annual rate of -8.3% and net profit at -15.1%. Past growth does not indicate future results.

What is the EPS of Abbott India?

Annual EPS for Mar 2023 was ₹446.80.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Abbott India With ATS

Track ABBOTINDIA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.